 | • レポートコード：MRC2Q12-01121 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、バイオメディカルポリ乳酸のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 バイオメディカルポリ乳酸のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 バイオメディカルポリ乳酸の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 バイオメディカルポリ乳酸のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのバイオメディカルポリ乳酸の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のバイオメディカルポリ乳酸の売上および2028年までの予測に焦点を当てています。 バイオメディカルポリ乳酸のグローバル主要企業には、NatureWorks LLC、Futerro、Sulzer Ltd、BASF SE、Corbion Purac、Zhejiang Hisun Biomaterials Co. Ltd、Danimer Scientific、Zimmer Biomet、TotalEnergies Corbion、Jiangsu Jiuding Group、Polysciences Inc.、BEWiSynbra Group、Takiron Co., Ltd.、Chongqing bofei biochemical products、COFCO Group、Conmedなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 バイオメディカルポリ乳酸市場は、タイプとアプリケーションによって区分されます。世界のバイオメディカルポリ乳酸市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 ポリ（L-乳酸）、ポリ（D-乳酸）、ポリ（DL-乳酸） 【アプリケーション別セグメント】 医療用インプラント、組織工学、整形外科用機器、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - バイオメディカルポリ乳酸製品概要 - タイプ別市場（ポリ（L-乳酸）、ポリ（D-乳酸）、ポリ（DL-乳酸）） - アプリケーション別市場（医療用インプラント、組織工学、整形外科用機器、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のバイオメディカルポリ乳酸販売量予測2017-2028 - 世界のバイオメディカルポリ乳酸売上予測2017-2028 - バイオメディカルポリ乳酸の地域別販売量 - バイオメディカルポリ乳酸の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別バイオメディカルポリ乳酸販売量 - 主要メーカー別バイオメディカルポリ乳酸売上 - 主要メーカー別バイオメディカルポリ乳酸価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（ポリ（L-乳酸）、ポリ（D-乳酸）、ポリ（DL-乳酸）） - バイオメディカルポリ乳酸のタイプ別販売量 - バイオメディカルポリ乳酸のタイプ別売上 - バイオメディカルポリ乳酸のタイプ別価格 ・アプリケーション別市場規模（医療用インプラント、組織工学、整形外科用機器、その他） - バイオメディカルポリ乳酸のアプリケーション別販売量 - バイオメディカルポリ乳酸のアプリケーション別売上 - バイオメディカルポリ乳酸のアプリケーション別価格 ・北米市場 - 北米のバイオメディカルポリ乳酸市場規模（タイプ別、アプリケーション別） - 主要国別のバイオメディカルポリ乳酸市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのバイオメディカルポリ乳酸市場規模（タイプ別、アプリケーション別） - 主要国別のバイオメディカルポリ乳酸市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のバイオメディカルポリ乳酸市場規模（タイプ別、アプリケーション別） - 主要国別のバイオメディカルポリ乳酸市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のバイオメディカルポリ乳酸市場規模（タイプ別、アプリケーション別） - 主要国別のバイオメディカルポリ乳酸市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのバイオメディカルポリ乳酸市場規模（タイプ別、アプリケーション別） - 主要国別のバイオメディカルポリ乳酸市場規模（トルコ、サウジアラビア） ・企業情報 NatureWorks LLC、Futerro、Sulzer Ltd、BASF SE、Corbion Purac、Zhejiang Hisun Biomaterials Co. Ltd、Danimer Scientific、Zimmer Biomet、TotalEnergies Corbion、Jiangsu Jiuding Group、Polysciences Inc.、BEWiSynbra Group、Takiron Co., Ltd.、Chongqing bofei biochemical products、COFCO Group、Conmed ・産業チェーン及び販売チャネル分析 - バイオメディカルポリ乳酸の産業チェーン分析 - バイオメディカルポリ乳酸の原材料 - バイオメディカルポリ乳酸の生産プロセス - バイオメディカルポリ乳酸の販売及びマーケティング - バイオメディカルポリ乳酸の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - バイオメディカルポリ乳酸の産業動向 - バイオメディカルポリ乳酸のマーケットドライバー - バイオメディカルポリ乳酸の課題 - バイオメディカルポリ乳酸の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Bio-Medical Polylactic Acid estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Bio-Medical Polylactic Acid is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Bio-Medical Polylactic Acid is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Bio-Medical Polylactic Acid is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Bio-Medical Polylactic Acid include NatureWorks LLC, Futerro, Sulzer Ltd, BASF SE, Corbion Purac, Zhejiang Hisun Biomaterials Co. Ltd, Danimer Scientific, Zimmer Biomet and TotalEnergies Corbion, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Bio-Medical Polylactic Acid production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Bio-Medical Polylactic Acid by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Bio-Medical Polylactic Acid manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Bio-Medical Polylactic Acid market. Further, it explains the major drivers and regional dynamics of the global Bio-Medical Polylactic Acid market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
NatureWorks LLC
Futerro
Sulzer Ltd
BASF SE
Corbion Purac
Zhejiang Hisun Biomaterials Co. Ltd
Danimer Scientific
Zimmer Biomet
TotalEnergies Corbion
Jiangsu Jiuding Group
Polysciences Inc.
BEWiSynbra Group
Takiron Co., Ltd.
Chongqing bofei biochemical products
COFCO Group
Conmed
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Bio-Medical Polylactic Acid Segment by Type
Poly(L-lactic) Acid
Poly(D-lactic) Acid
Poly(DL-lactic) Acid
Bio-Medical Polylactic Acid Segment by Application
Medical Implants
Tissue Engineering
Orthopedic Devices
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Bio-Medical Polylactic Acid production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Bio-Medical Polylactic Acid market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Bio-Medical Polylactic Acid, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Bio-Medical Polylactic Acid, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Bio-Medical Polylactic Acid, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bio-Medical Polylactic Acid sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Bio-Medical Polylactic Acid market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Bio-Medical Polylactic Acid sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including NatureWorks LLC, Futerro, Sulzer Ltd, BASF SE, Corbion Purac, Zhejiang Hisun Biomaterials Co. Ltd, Danimer Scientific, Zimmer Biomet and TotalEnergies Corbion, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Bio-Medical Polylactic Acid capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Bio-Medical Polylactic Acid in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Bio-Medical Polylactic Acid manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bio-Medical Polylactic Acid sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 Study Coverage
1.1 Bio-Medical Polylactic Acid Product Introduction
1.2 Market by Type
1.2.1 Global Bio-Medical Polylactic Acid Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Poly(L-lactic) Acid
1.2.3 Poly(D-lactic) Acid
1.2.4 Poly(DL-lactic) Acid
1.3 Market by Application
1.3.1 Global Bio-Medical Polylactic Acid Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Medical Implants
1.3.3 Tissue Engineering
1.3.4 Orthopedic Devices
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Bio-Medical Polylactic Acid Production
2.1 Global Bio-Medical Polylactic Acid Production Capacity (2017-2028)
2.2 Global Bio-Medical Polylactic Acid Production by Region: 2017 VS 2021 VS 2028
2.3 Global Bio-Medical Polylactic Acid Production by Region
2.3.1 Global Bio-Medical Polylactic Acid Historic Production by Region (2017-2022)
2.3.2 Global Bio-Medical Polylactic Acid Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Bio-Medical Polylactic Acid Sales in Volume & Value Estimates and Forecasts
3.1 Global Bio-Medical Polylactic Acid Sales Estimates and Forecasts 2017-2028
3.2 Global Bio-Medical Polylactic Acid Revenue Estimates and Forecasts 2017-2028
3.3 Global Bio-Medical Polylactic Acid Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Bio-Medical Polylactic Acid Sales by Region
3.4.1 Global Bio-Medical Polylactic Acid Sales by Region (2017-2022)
3.4.2 Global Sales Bio-Medical Polylactic Acid by Region (2023-2028)
3.5 Global Bio-Medical Polylactic Acid Revenue by Region
3.5.1 Global Bio-Medical Polylactic Acid Revenue by Region (2017-2022)
3.5.2 Global Bio-Medical Polylactic Acid Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Bio-Medical Polylactic Acid Production Capacity by Manufacturers
4.2 Global Bio-Medical Polylactic Acid Sales by Manufacturers
4.2.1 Global Bio-Medical Polylactic Acid Sales by Manufacturers (2017-2022)
4.2.2 Global Bio-Medical Polylactic Acid Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Bio-Medical Polylactic Acid in 2021
4.3 Global Bio-Medical Polylactic Acid Revenue by Manufacturers
4.3.1 Global Bio-Medical Polylactic Acid Revenue by Manufacturers (2017-2022)
4.3.2 Global Bio-Medical Polylactic Acid Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Bio-Medical Polylactic Acid Revenue in 2021
4.4 Global Bio-Medical Polylactic Acid Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Bio-Medical Polylactic Acid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Bio-Medical Polylactic Acid Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Bio-Medical Polylactic Acid Sales by Type
5.1.1 Global Bio-Medical Polylactic Acid Historical Sales by Type (2017-2022)
5.1.2 Global Bio-Medical Polylactic Acid Forecasted Sales by Type (2023-2028)
5.1.3 Global Bio-Medical Polylactic Acid Sales Market Share by Type (2017-2028)
5.2 Global Bio-Medical Polylactic Acid Revenue by Type
5.2.1 Global Bio-Medical Polylactic Acid Historical Revenue by Type (2017-2022)
5.2.2 Global Bio-Medical Polylactic Acid Forecasted Revenue by Type (2023-2028)
5.2.3 Global Bio-Medical Polylactic Acid Revenue Market Share by Type (2017-2028)
5.3 Global Bio-Medical Polylactic Acid Price by Type
5.3.1 Global Bio-Medical Polylactic Acid Price by Type (2017-2022)
5.3.2 Global Bio-Medical Polylactic Acid Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Bio-Medical Polylactic Acid Sales by Application
6.1.1 Global Bio-Medical Polylactic Acid Historical Sales by Application (2017-2022)
6.1.2 Global Bio-Medical Polylactic Acid Forecasted Sales by Application (2023-2028)
6.1.3 Global Bio-Medical Polylactic Acid Sales Market Share by Application (2017-2028)
6.2 Global Bio-Medical Polylactic Acid Revenue by Application
6.2.1 Global Bio-Medical Polylactic Acid Historical Revenue by Application (2017-2022)
6.2.2 Global Bio-Medical Polylactic Acid Forecasted Revenue by Application (2023-2028)
6.2.3 Global Bio-Medical Polylactic Acid Revenue Market Share by Application (2017-2028)
6.3 Global Bio-Medical Polylactic Acid Price by Application
6.3.1 Global Bio-Medical Polylactic Acid Price by Application (2017-2022)
6.3.2 Global Bio-Medical Polylactic Acid Price Forecast by Application (2023-2028)
7 North America
7.1 North America Bio-Medical Polylactic Acid Market Size by Type
7.1.1 North America Bio-Medical Polylactic Acid Sales by Type (2017-2028)
7.1.2 North America Bio-Medical Polylactic Acid Revenue by Type (2017-2028)
7.2 North America Bio-Medical Polylactic Acid Market Size by Application
7.2.1 North America Bio-Medical Polylactic Acid Sales by Application (2017-2028)
7.2.2 North America Bio-Medical Polylactic Acid Revenue by Application (2017-2028)
7.3 North America Bio-Medical Polylactic Acid Sales by Country
7.3.1 North America Bio-Medical Polylactic Acid Sales by Country (2017-2028)
7.3.2 North America Bio-Medical Polylactic Acid Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Bio-Medical Polylactic Acid Market Size by Type
8.1.1 Europe Bio-Medical Polylactic Acid Sales by Type (2017-2028)
8.1.2 Europe Bio-Medical Polylactic Acid Revenue by Type (2017-2028)
8.2 Europe Bio-Medical Polylactic Acid Market Size by Application
8.2.1 Europe Bio-Medical Polylactic Acid Sales by Application (2017-2028)
8.2.2 Europe Bio-Medical Polylactic Acid Revenue by Application (2017-2028)
8.3 Europe Bio-Medical Polylactic Acid Sales by Country
8.3.1 Europe Bio-Medical Polylactic Acid Sales by Country (2017-2028)
8.3.2 Europe Bio-Medical Polylactic Acid Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Bio-Medical Polylactic Acid Market Size by Type
9.1.1 Asia Pacific Bio-Medical Polylactic Acid Sales by Type (2017-2028)
9.1.2 Asia Pacific Bio-Medical Polylactic Acid Revenue by Type (2017-2028)
9.2 Asia Pacific Bio-Medical Polylactic Acid Market Size by Application
9.2.1 Asia Pacific Bio-Medical Polylactic Acid Sales by Application (2017-2028)
9.2.2 Asia Pacific Bio-Medical Polylactic Acid Revenue by Application (2017-2028)
9.3 Asia Pacific Bio-Medical Polylactic Acid Sales by Region
9.3.1 Asia Pacific Bio-Medical Polylactic Acid Sales by Region (2017-2028)
9.3.2 Asia Pacific Bio-Medical Polylactic Acid Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Bio-Medical Polylactic Acid Market Size by Type
10.1.1 Latin America Bio-Medical Polylactic Acid Sales by Type (2017-2028)
10.1.2 Latin America Bio-Medical Polylactic Acid Revenue by Type (2017-2028)
10.2 Latin America Bio-Medical Polylactic Acid Market Size by Application
10.2.1 Latin America Bio-Medical Polylactic Acid Sales by Application (2017-2028)
10.2.2 Latin America Bio-Medical Polylactic Acid Revenue by Application (2017-2028)
10.3 Latin America Bio-Medical Polylactic Acid Sales by Country
10.3.1 Latin America Bio-Medical Polylactic Acid Sales by Country (2017-2028)
10.3.2 Latin America Bio-Medical Polylactic Acid Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Bio-Medical Polylactic Acid Market Size by Type
11.1.1 Middle East and Africa Bio-Medical Polylactic Acid Sales by Type (2017-2028)
11.1.2 Middle East and Africa Bio-Medical Polylactic Acid Revenue by Type (2017-2028)
11.2 Middle East and Africa Bio-Medical Polylactic Acid Market Size by Application
11.2.1 Middle East and Africa Bio-Medical Polylactic Acid Sales by Application (2017-2028)
11.2.2 Middle East and Africa Bio-Medical Polylactic Acid Revenue by Application (2017-2028)
11.3 Middle East and Africa Bio-Medical Polylactic Acid Sales by Country
11.3.1 Middle East and Africa Bio-Medical Polylactic Acid Sales by Country (2017-2028)
11.3.2 Middle East and Africa Bio-Medical Polylactic Acid Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 NatureWorks LLC
12.1.1 NatureWorks LLC Corporation Information
12.1.2 NatureWorks LLC Overview
12.1.3 NatureWorks LLC Bio-Medical Polylactic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 NatureWorks LLC Bio-Medical Polylactic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 NatureWorks LLC Recent Developments
12.2 Futerro
12.2.1 Futerro Corporation Information
12.2.2 Futerro Overview
12.2.3 Futerro Bio-Medical Polylactic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Futerro Bio-Medical Polylactic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Futerro Recent Developments
12.3 Sulzer Ltd
12.3.1 Sulzer Ltd Corporation Information
12.3.2 Sulzer Ltd Overview
12.3.3 Sulzer Ltd Bio-Medical Polylactic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Sulzer Ltd Bio-Medical Polylactic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Sulzer Ltd Recent Developments
12.4 BASF SE
12.4.1 BASF SE Corporation Information
12.4.2 BASF SE Overview
12.4.3 BASF SE Bio-Medical Polylactic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 BASF SE Bio-Medical Polylactic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 BASF SE Recent Developments
12.5 Corbion Purac
12.5.1 Corbion Purac Corporation Information
12.5.2 Corbion Purac Overview
12.5.3 Corbion Purac Bio-Medical Polylactic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Corbion Purac Bio-Medical Polylactic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Corbion Purac Recent Developments
12.6 Zhejiang Hisun Biomaterials Co. Ltd
12.6.1 Zhejiang Hisun Biomaterials Co. Ltd Corporation Information
12.6.2 Zhejiang Hisun Biomaterials Co. Ltd Overview
12.6.3 Zhejiang Hisun Biomaterials Co. Ltd Bio-Medical Polylactic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Zhejiang Hisun Biomaterials Co. Ltd Bio-Medical Polylactic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Zhejiang Hisun Biomaterials Co. Ltd Recent Developments
12.7 Danimer Scientific
12.7.1 Danimer Scientific Corporation Information
12.7.2 Danimer Scientific Overview
12.7.3 Danimer Scientific Bio-Medical Polylactic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Danimer Scientific Bio-Medical Polylactic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Danimer Scientific Recent Developments
12.8 Zimmer Biomet
12.8.1 Zimmer Biomet Corporation Information
12.8.2 Zimmer Biomet Overview
12.8.3 Zimmer Biomet Bio-Medical Polylactic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Zimmer Biomet Bio-Medical Polylactic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Zimmer Biomet Recent Developments
12.9 TotalEnergies Corbion
12.9.1 TotalEnergies Corbion Corporation Information
12.9.2 TotalEnergies Corbion Overview
12.9.3 TotalEnergies Corbion Bio-Medical Polylactic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 TotalEnergies Corbion Bio-Medical Polylactic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 TotalEnergies Corbion Recent Developments
12.10 Jiangsu Jiuding Group
12.10.1 Jiangsu Jiuding Group Corporation Information
12.10.2 Jiangsu Jiuding Group Overview
12.10.3 Jiangsu Jiuding Group Bio-Medical Polylactic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Jiangsu Jiuding Group Bio-Medical Polylactic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Jiangsu Jiuding Group Recent Developments
12.11 Polysciences Inc.
12.11.1 Polysciences Inc. Corporation Information
12.11.2 Polysciences Inc. Overview
12.11.3 Polysciences Inc. Bio-Medical Polylactic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Polysciences Inc. Bio-Medical Polylactic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Polysciences Inc. Recent Developments
12.12 BEWiSynbra Group
12.12.1 BEWiSynbra Group Corporation Information
12.12.2 BEWiSynbra Group Overview
12.12.3 BEWiSynbra Group Bio-Medical Polylactic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 BEWiSynbra Group Bio-Medical Polylactic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 BEWiSynbra Group Recent Developments
12.13 Takiron Co., Ltd.
12.13.1 Takiron Co., Ltd. Corporation Information
12.13.2 Takiron Co., Ltd. Overview
12.13.3 Takiron Co., Ltd. Bio-Medical Polylactic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Takiron Co., Ltd. Bio-Medical Polylactic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Takiron Co., Ltd. Recent Developments
12.14 Chongqing bofei biochemical products
12.14.1 Chongqing bofei biochemical products Corporation Information
12.14.2 Chongqing bofei biochemical products Overview
12.14.3 Chongqing bofei biochemical products Bio-Medical Polylactic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 Chongqing bofei biochemical products Bio-Medical Polylactic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Chongqing bofei biochemical products Recent Developments
12.15 COFCO Group
12.15.1 COFCO Group Corporation Information
12.15.2 COFCO Group Overview
12.15.3 COFCO Group Bio-Medical Polylactic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 COFCO Group Bio-Medical Polylactic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 COFCO Group Recent Developments
12.16 Conmed
12.16.1 Conmed Corporation Information
12.16.2 Conmed Overview
12.16.3 Conmed Bio-Medical Polylactic Acid Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 Conmed Bio-Medical Polylactic Acid Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Conmed Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Bio-Medical Polylactic Acid Industry Chain Analysis
13.2 Bio-Medical Polylactic Acid Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Bio-Medical Polylactic Acid Production Mode & Process
13.4 Bio-Medical Polylactic Acid Sales and Marketing
13.4.1 Bio-Medical Polylactic Acid Sales Channels
13.4.2 Bio-Medical Polylactic Acid Distributors
13.5 Bio-Medical Polylactic Acid Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Bio-Medical Polylactic Acid Industry Trends
14.2 Bio-Medical Polylactic Acid Market Drivers
14.3 Bio-Medical Polylactic Acid Market Challenges
14.4 Bio-Medical Polylactic Acid Market Restraints
15 Key Finding in The Global Bio-Medical Polylactic Acid Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer